Up- and down-regulation of calpain inhibitor polypeptide, calpastatin, in postischemic hippocampus

Neurosci Lett. 1997 May 16;227(2):75-8. doi: 10.1016/s0304-3940(97)00309-1.

Abstract

Based on our previous observation that transient forebrain ischemia induces calpain-catalyzed proteolysis in gerbil hippocampus in a region-specific manner, we examined the effect of ischemia on the quantity and localization of the endogenous calpain-specific inhibitor protein, calpastatin, in the tissue. Brief (5 min) forebrain ischemia followed by reperfusion induced an overall increase of calpastatin immunoreactivity in hippocampus, particularly in pyramidal cells, in 4 h as analyzed by Western blotting and immunohistochemistry. The amount of calpastatin, however, decreased to the preischemic level and lower in 24 h to 7 days due to proteolysis except in CA2 showing continuously elevated calpastatin immunoreactivity. Because calpastatin is not only a potent inhibitor but also a preferred substrate for calpain and because CA2 neurons are less vulnerable to ischemic stress than the adjacent CA1 neurons, these observations imply involvement of calpastatin in calpain regulation as a bait substrate and, possibly, in neuroprotection under ischemic conditions. Calpastatin may participate in the stress responses together with the previously known ischemia-induced stress proteins such as heat shock proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy*
  • Calcium-Binding Proteins / pharmacology*
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Down-Regulation / drug effects*
  • Female
  • Gerbillinae
  • Hippocampus / drug effects*
  • Immunohistochemistry
  • Up-Regulation / drug effects*

Substances

  • Calcium-Binding Proteins
  • Cysteine Proteinase Inhibitors
  • calpastatin